News Focus
News Focus
Followers 77
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: XenaLives post# 3077

Monday, 04/10/2017 11:43:37 AM

Monday, April 10, 2017 11:43:37 AM

Post# of 21574
Your 2nd concern is valid -

Going into P2b - and so what? They decided to take risk - the no of patients is large so it will give good baseline for next phase trial - if it fails - no issues

On share structure - it is overblown concern as
- if trial successful - the SP will spike disproportionately
- if trial fails - everyone loses - even a stock like AVXL with wide holding went from $7.50 to $2.30 in just 3 days
So it is not different that any other biotech
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TAOX News